Biopharmaceutical Products, Indications, and Targets: Past, Present, and Future

摘要

Over the past 15 years, the BioProcess Technology Group (BPTG, formerly BioProcess Technology Consultants) has built and maintained the proprietary internal bioTRAK database to track recombinant biopharmaceutical products from preclinical developmentthrough US and Ell commercialization. In addition, the firm is watching other biopharmaceutical markets, including for gene therapies and modified cell therapies. BPTG also is considering regional products for regional markets and tracking manufacturingcapacity required to manufacture biopharmaceuticals for US and EU markets.